92 results
Page 2 of 5
8-K
EX-99.1
9il75wwussnz
6 Jul 23
ENDRA Life Sciences Announces Adjournment of
5:25pm
DEFA14A
EX-99.1
tgxps0 cul3ty0tzild
6 Jul 23
Additional proxy soliciting materials
5:25pm
8-K
EX-99.1
291o0fs4q0p
15 May 23
ENDRA Life Sciences Reports First Quarter 2023 Financial Results and Provides a Business Update
12:00am
8-K
EX-99.1
okvwi8pa1 e70
2 May 23
ENDRA Life Sciences Announces Pricing of Upsized $4.5 Million Public Offering
4:16pm
8-K
EX-99.2
mspoy eq7dn
2 May 23
ENDRA Life Sciences Announces Pricing of Upsized $4.5 Million Public Offering
4:16pm
424B5
otj6a vfuqc
28 Apr 23
Prospectus supplement for primary offering
4:51pm
8-K
EX-99.1
vyhyry sbf8ea
14 Nov 22
ENDRA Life Sciences Reports Third Quarter 2022 Financial Results and Provides Business Update
4:32pm
8-K
EX-99.1
afrfkp nv4vchwxj1
15 Aug 22
ENDRA Life Sciences Reports Second Quarter 2022 Financial Results and Provides Business Update
5:17pm
8-K
EX-99.1
0gwszu0wy
12 May 22
ENDRA Life Sciences Reports First Quarter 2022 Financial Results and Provides Business Update
4:06pm
8-K
EX-99.1
iu92sj2 7z
21 Apr 22
Regulation FD Disclosure
8:08am
8-K
EX-99.1
off1e1u
30 Mar 22
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
4:11pm
8-K
EX-99.1
e423ebsy dk
10 Feb 22
ENDRA Life Sciences Provides Update on U.S. Regulatory Strategy for its TAEUS® System
8:00am
8-K
EX-99.1
ev8iby
15 Nov 21
ENDRA Life Sciences Reports Third Quarter 2021 Financial Results and Provides Business Update
4:18pm